RetinalGenix Technologies Contracts with Seer Bio to Explore Early Detection of Neurodegenerative, Systemic, and Retinal Diseases

(Other OTC:RTGN),(OTC US:RTGN),(NASDAQ:SEER), APOLLO BEACH, Fla., Oct. 16, 2025 (GLOBE NEWSWIRE) — RetinalGenix Technologies Inc. [OTCQB: RTGN] (“RetinalGenix” or the “Company”), a company developing ultra-high-resolution retinal imaging technology, today announced it has engaged Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, to help identify novel biomarkers that […]

CREA Updates Resale Housing Market Forecasts for 2025 and 2026

OTTAWA, Ontario, Oct. 16, 2025 (GLOBE NEWSWIRE) — The Canadian Real Estate Association (CREA) has updated its 2025 and 2026 forecasts for home sales activity and average home prices via the Multiple Listing Service(R) (MLS(R)) Systems of Canadian real estate boards and associations. In 2024, CREA forecast a recovery year in Canada's resale housing markets,

RetinalGenix Technologies Contracts with Seer Bio to Explore Early Detection of Neurodegenerative, Systemic, and Retinal Diseases

RetinalGenix Technologies Contracts with Seer Bio to Explore Early Detection of Neurodegenerative, Systemic, and Retinal Diseases GlobeNewswire October 16, 2025 APOLLO BEACH, Fla., Oct. 16, 2025 (GLOBE NEWSWIRE) — RetinalGenix Technologies Inc. [OTCQB: RTGN] (“RetinalGenix” or the “Company”), a company developing ultra-high-resolution retinal imaging technology, today announced it has engaged Seer, Inc. (Nasdaq: SEER), a

Best Window Treatment Trade Program (2025): SelectBlinds Named Top Choice for Designers and Contractors by Expert Consumers

Expert Consumers has named SelectBlinds the top window treatment trade program for designers and contractors in 2025, citing the company's combination of affordability, product range, and ease of access for professionals working across residential and commercial interiors. Top Window Treatment Trade Program — SelectBlinds – a trade program that offers designers, contractors, and builders discounted

Veronica Aroutiunian Joins Debevoise’s Luxembourg Office as Funds Partner

Debevoise & Plimpton LLP announces that Veronica Aroutiunian has joined the firm's Investment Management Group as a partner, resident in the firm's Luxembourg office. Recognized as one of Luxembourg's leading investment fund advisors, Ms.Aroutiunian brings extensive experience advising clients in the regulatory and corporate aspects of structuring, establishing and operating investment funds, with particular expertise

Automotive Rubber Seals Market worth $10.74 billion by 2032 | MarketsandMarkets™

Theautomotive rubber seals market is estimated to grow from USD 8.40 billion in 2025 to USD 10.74 billion by 2032, with a CAGR of 3.6%, according to a new report by MarketsandMarkets™.Rising regulatory requirements for vehicle safety, noise reduction, and standards such as ECE R43 (glazing safety), FMVSS 205 (sealing performance), and stricter cabin airtightness

CREA Updates Resale Housing Market Forecasts for 2025 and 2026

CREA Updates Resale Housing Market Forecasts for 2025 and 2026 GlobeNewswire October 16, 2025 OTTAWA, Ontario, Oct. 16, 2025 (GLOBE NEWSWIRE) — The Canadian Real Estate Association (CREA) has updated its 2025 and 2026 forecasts for home sales activity and average home prices via the Multiple Listing Service(R) (MLS(R)) Systems of Canadian real estate boards

Lost Money on PubMatic, Inc. (PUBM)? Contact Levi & Korsinsky to Join Class Action Before October 20, 2025

NEW YORK CITY, NY / ACCESS Newswire / October 16, 2025 / NEW YORK, NY / ACCESS Newswire / October 16, 2025 / If you suffered a loss on your PubMatic, Inc. (NASDAQ:PUBM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/pubmatic-inc-lawsuit-submission-form?prid=172440&wire=1&utm_campaign=20

ENT and Allergy Associates, LLP Welcomes Ethan Moritz, MD to Its Offices in Woodbury and Voorhees, NJ

Tarrytown, New York, Oct. 16, 2025 (GLOBE NEWSWIRE) — ENT and Allergy Associates, LLP (ENTA), the nation's largest ENT, allergy, and audiology practice, is proud to announce that otolaryngologist Ethan Moritz, MD has joined its team of world-class specialists, starting January 1, 2026. Dr. Moritz will provide comprehensive ear, nose, and throat care for adult

Aicuris Announces Pritelivir Met Primary Endpoint in Immunocompromised Patients with Refractory Herpes Simplex Virus in Phase 3 Pivotal Trial

Pritelivir demonstrated clinically meaningful and highly statistically significant superiority (p=0.0047) in lesion healing up to 28 days of treatment, compared with standard-of-care (SoC) treatments in refractory Herpes Simplex Virus (HSV) infected immunocompromised patients Pritelivir was well tolerated and had a favorable safety profile over the treatment duration Full results will be presented at an upcoming

Scroll to Top